SG Americas Securities’s Affimed AFMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-6,791
Closed -$51K 2238
2023
Q1
$51K Buy
6,791
+4,722
+228% +$47.2K ﹤0.01% 3067
2022
Q4
$26K Sell
2,069
-2,371
-53% -$41.6K ﹤0.01% 2907
2022
Q3
$91K Buy
+4,440
New +$123K ﹤0.01% 2878
2022
Q1
Sell
-1,550
Closed -$86K 2922
2021
Q4
$86K Sell
1,550
-3,959
-72% -$245K ﹤0.01% 3115
2021
Q3
$340K Buy
+5,509
New +$363K ﹤0.01% 2828
2021
Q2
Sell
-2,191
Closed -$173K 2822
2021
Q1
$173K Buy
+2,191
New +$142K ﹤0.01% 2766
2020
Q3
Sell
-4,026
Closed -$186K 2654
2020
Q2
$186K Buy
4,026
+987
+32% +$27.5K ﹤0.01% 2916
2020
Q1
$48K Buy
+3,039
New +$72.4K ﹤0.01% 3183

Other funds holding AFMD

SG Americas Securities's AFMD Position: Q2 2023 in Review

SG Americas Securities sold out of Affimed (AFMD) in Q2 2023, closing a stake of 6,791 shares — an estimated $51K sold.

SG Americas Securities first reported a position in AFMD in Q1 2020 and held it in 8 quarters. The position peaked at $340K in Q3 2021. 80 funds tracked by Wall St. Rank hold AFMD as of Q2 2023.

  • SG Americas Securities reported no remaining Affimed position as of Q2 2023 after selling out during the quarter.
  • SG Americas Securities sold 6,791 Affimed shares in Q2 2023, an estimated $51K.
  • SG Americas Securities first reported a position in Affimed in Q1 2020 and held it in 8 quarters.
  • SG Americas Securities's Affimed position peaked at $340K in Q3 2021.
  • 80 funds tracked by Wall St. Rank held Affimed as of Q2 2023.

Based on SG Americas Securities's 13F filing for Q2 2023, filed 10 Jul 2023.